SCHEMBL3035330

SCHEMBL3035330

O=[N+]([O-])c1ccc(F)c(F)c1Oc1cccc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
HSPB1 P04792 2/20 0.50
PIN1 Q13526 2/20 0.49
PTGES O14684 2/20 0.46
MAPT P10636 5/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
RECQL P46063 2/20 0.43
TDP1 Q9NUW8 3/20 0.41
ALOX5 P09917 2/20 0.40
HPRT1 P00492 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CTSB P07858 1/20 0.39
ATM Q13315 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3027901 0.87 PIN1 (0.50) ALDH1A1HSPB1PIN1PTGESMAPT
SCHEMBL10422427 0.84 ALDH1A1 (0.68) ALDH1A1HSPB1PIN1PTGESMAPT
SCHEMBL3033563 0.81 TDP1 (0.44) ALDH1A1HSPB1PIN1PTGESMAPT
SCHEMBL13657593 0.80 HSPB1 (0.46) ALDH1A1HSPB1PIN1MAPTLMNA
SCHEMBL3032884 0.77 TDP1 (0.46) ALDH1A1HSPB1PIN1PTGESMAPT
SCHEMBL20222275 0.76 ALDH1A1 (0.65) ALDH1A1PIN1PTGESMAPTLMNA
SCHEMBL21685849 0.76 HSPB1 (0.74) ALDH1A1HSPB1MAPTLMNAHTT
SCHEMBL3023941 0.76 PIN1 (0.41) ALDH1A1HSPB1PIN1PTGESMAPT
SCHEMBL28151906 0.75 ALDH1A1 (0.48) ALDH1A1PIN1PTGESMAPTLMNA
SCHEMBL3023944 0.75 PIN1 (0.40) ALDH1A1HSPB1PIN1PTGESMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed
EP-2166856-A1 CHEMICAL COMPOUNDS GlaxoSmithKline LLC (US) 2010-03-31 EP disclosed
WO-2008154271-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 ALDH1A1 348/4885HSPB1 4391/4885PIN1 366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.